Through the 90-day period concluding January 10, 2026, Acadia Pharmaceuticals's top three insider stakeholders include Director Bros. Advisors Lp Baker (39.47Mn shares), Ceo Stephen Davis (186.56K shares), Evp And Coo And Head Of Commercial Brendan Teehan (62.10K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bros. Advisors Lp Baker | 39,468,841 | 05 Jun, 2023 | |
| Stephen Davis | Ceo | 186,555 | 20 Aug, 2024 |
| Brendan Teehan | Evp And Coo And Head Of Commercial | 62,105 | 19 Nov, 2024 |
| Srdjan R. Stankovic | President | 61,234 | 22 Nov, 2022 |
| Mark C. Schneyer | Evp And Chief Financial Officer | 53,338 | 19 Nov, 2025 |
| Austin D. Kim | Evp Andgeneral Counsel And Secretary | 46,901 | 09 Jan, 2024 |
| Daniel B Soland | 44,041 | 02 Jun, 2025 | |
| Edmund Harrigan | 35,041 | 02 Jun, 2025 | |
| Elizabeth A. Garofalo | 25,382 | 03 Sep, 2025 | |
| James Kihara | Principal Accounting Officer | 25,058 | 19 Nov, 2025 |
| Adora Ndu | 24,801 | 02 Jun, 2025 | |
| Laura Brege | 15,095 | 05 Jun, 2025 | |
| Elena Ridloff | Evp And Cfo | 10,553 | 30 Apr, 2021 |
| James M Daly | 4,041 | 12 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Nov, 2025 | James Kihara | Common Stock | D | 4,084 | $23.69 | 25,058 | D | S |
| 18 Nov, 2025 | Mark C. Schneyer | Common Stock | D | 10,262 | $23.69 | 53,338 | D | S |
| 17 Nov, 2025 | James Kihara | Common Stock | A | 3,966 | - | 29,142 | D | M |
| 17 Nov, 2025 | James Kihara | Common Stock | A | 3,966 | - | 25,176 | D | M |
| 17 Nov, 2025 | Mark C. Schneyer | Common Stock | A | 9,913 | - | 63,600 | D | M |
| 17 Nov, 2025 | Mark C. Schneyer | Common Stock | A | 9,913 | - | 53,687 | D | M |
| 10 Nov, 2025 | James M Daly | Common Stock | D | 30,000 | $22.37 | 4,041 | D | S |
| 15 Sep, 2025 | Mark C. Schneyer | Common Stock | D | 3,498 | $23.65 | 43,447 | D | S |
| 12 Sep, 2025 | Mark C. Schneyer | Common Stock | A | 6,815 | $0.00 | 46,945 | D | A |
| 02 Sep, 2025 | Elizabeth A. Garofalo | Common Stock | D | 1,600 | $25.98 | 25,382 | D | S |
| 02 Sep, 2025 | Elizabeth A. Garofalo | - | - | 25,382 | D | |||
| 18 Aug, 2025 | Mark C. Schneyer | Common Stock | D | 22,000 | $25.18 | 40,130 | D | S |
| 04 Jun, 2025 | Laura Brege | Common Stock | D | 14,446 | $21.78 | 15,095 | D | S |
| 29 May, 2025 | Edmund Harrigan | Common Stock | A | 9,387 | - | 35,041 | D | M |
| 29 May, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 16,214 | $0.00 | 39,365,965 | I | A |
| 29 May, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 16,214 | $0.00 | 3,658,735 | I | A |
| 29 May, 2025 | Bros. Advisors Lp Baker | - | - | 39,365,965 | I | |||
| 29 May, 2025 | Daniel B Soland | Common Stock | A | 9,387 | - | 44,041 | D | M |
| 29 May, 2025 | Laura Brege | Common Stock | A | 9,387 | - | 29,541 | D | M |
| 29 May, 2025 | James M Daly | Common Stock | A | 9,387 | - | 34,041 | D | M |